Adult T-cell leukemia differential diagnosis: Difference between revisions
m (Bot: Removing from Primary care) |
|||
(8 intermediate revisions by 5 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Adult_T-cell_leukemia]] | |||
{{CMG}} {{AE}} {{HL}} | {{CMG}}; {{AE}} {{HL}}; {{GRR}} {{Nat}} | ||
==Overview== | ==Overview== | ||
Adult T-cell leukemia must be differentiated from other diseases that cause [[weight loss]], [[night sweats]], [[hepatosplenomegaly]], and palpable [[lymph node]]s, such as [[hairy cell leukaemia]], prolymphocytic leukaemia, [[follicular lymphoma]], and [[mantle cell lymphoma]]. | Adult T-cell leukemia must be differentiated from other diseases that cause [[weight loss]], [[night sweats]], [[hepatosplenomegaly]], and palpable [[lymph node]]s, such as [[hairy cell leukaemia]], prolymphocytic leukaemia, [[follicular lymphoma]], and [[mantle cell lymphoma]]. | ||
== | ==Differentiating Adult T-cell Leukemia from other Diseases== | ||
* Adult T-cell leukemia must be differentiated from other diseases that cause [[weight loss]], | * Adult T-cell leukemia must be differentiated from other diseases that cause [[weight loss]], [[night sweats]], [[hepatosplenomegaly]], and palpable [[lymph node]]s, such as [[hairy cell leukaemia]], prolymphocytic leukaemia, [[follicular lymphoma]], and [[mantle cell lymphoma]].<ref name="wiki">Adult T-cell leukemia/lymphoma. Wikipedia (2015) https://en.wikipedia.org/wiki/Adult_T-cell_leukemia/lymphoma Accessed on November, 3 2015</ref><ref name="pmid20198459">{{cite journal |vauthors=Chuang SS, Ichinohasama R, Chu JS, Ohshima K |title=Differential diagnosis of angioimmunoblastic T-cell lymphoma with seropositivity for anti-HTLV antibody from adult T-cell leukemia/lymphoma |journal=Int. J. Hematol. |volume=91 |issue=4 |pages=687–91 |date=May 2010 |pmid=20198459 |doi=10.1007/s12185-010-0540-x |url=}}</ref><ref name="H">Hoffbrand V, Moss P. Essential Haematology. John Wiley & Sons; 2011</ref><ref name="pmid29685460">{{cite journal |vauthors=Rodríguez-Zúñiga MJM, Cortez-Franco F, Qujiano-Gomero E |title=Adult T-Cell Leukemia/Lymphoma. Review of the Literature |journal=Actas Dermosifiliogr |volume=109 |issue=5 |pages=399–407 |date=June 2018 |pmid=29685460 |doi=10.1016/j.ad.2017.08.014 |url=}}</ref> | ||
* Based on the expression of cell surface markers, the table below differentiates adult T-cell leukemia from other diseases that cause similar clinical presentations: | * Based on the expression of cell surface markers, the table below differentiates adult T-cell leukemia from other diseases that cause similar clinical presentations: | ||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" | {| style="border: 0px; font-size: 90%; margin: 3px; width: 1000px" | ||
|+ | |+ | ||
! style="background: #4479BA; width: 600px;" | {{fontcolor|#FFF|'''Differential Diagnosis'''}} | ! style="background: #4479BA; width: 600px;" | {{fontcolor|#FFF|'''Differential Diagnosis'''}} | ||
Line 25: | Line 24: | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | ||
'''Chronic lymphocytic leukemia''' | '''Chronic lymphocytic leukemia''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Weakly positive | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Positive | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Negative | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Positive | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Negative | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Positive/Negative | |||
|- | |- | ||
Line 42: | Line 41: | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | ||
'''Prolymphocytic leukemia''' | '''Prolymphocytic leukemia''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Strongly positive | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Negative | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Positive | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Negative | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Positive | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Negative | |||
|- | |- | ||
Line 59: | Line 58: | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | ||
'''Hairy cell leukemia''' | '''Hairy cell leukemia''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Strongly positive | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Negative | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Positive | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Negative | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Positive/Negative | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Positive | |||
|- | |- | ||
Line 76: | Line 75: | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | ||
'''Mantle cell lymphoma''' | '''Mantle cell lymphoma''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Positive | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Positive | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Strongly positive | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Negative | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Strongly positive | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Negative | |||
|- | |- | ||
Line 93: | Line 92: | ||
| style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | | ||
'''Follicular lymphoma''' | '''Follicular lymphoma''' | ||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Strongly positive | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Negative | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Positive | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Negative | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Strongly positive | |||
| style="padding: 5px 5px; background: #F5F5F5;" align=center| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Negative | |||
|} | |} | ||
<br> | <br> | ||
Line 114: | Line 113: | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
[[Category:Medicine]] | |||
[[Category: | |||
[[Category:Hematology]] | [[Category:Hematology]] | ||
[[Category:Immunology]] | |||
[[Category:Infectious disease]] | |||
[[Category:Oncology]] | |||
[[Category:Up-To-Date]] |
Latest revision as of 20:18, 29 July 2020
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Haytham Allaham, M.D. [2]; Grammar Reviewer: Natalie Harpenau, B.S.[3]
Overview
Adult T-cell leukemia must be differentiated from other diseases that cause weight loss, night sweats, hepatosplenomegaly, and palpable lymph nodes, such as hairy cell leukaemia, prolymphocytic leukaemia, follicular lymphoma, and mantle cell lymphoma.
Differentiating Adult T-cell Leukemia from other Diseases
- Adult T-cell leukemia must be differentiated from other diseases that cause weight loss, night sweats, hepatosplenomegaly, and palpable lymph nodes, such as hairy cell leukaemia, prolymphocytic leukaemia, follicular lymphoma, and mantle cell lymphoma.[1][2][3][4]
- Based on the expression of cell surface markers, the table below differentiates adult T-cell leukemia from other diseases that cause similar clinical presentations:
Differential Diagnosis | Surface Immunoglobulin | CD5 | CD22/FMC7 | CD23 | CD79b | CD103 |
---|---|---|---|---|---|---|
Chronic lymphocytic leukemia |
Weakly positive |
Positive |
Negative |
Positive |
Negative |
Positive/Negative |
Prolymphocytic leukemia |
Strongly positive |
Negative |
Positive |
Negative |
Positive |
Negative |
Hairy cell leukemia |
Strongly positive |
Negative |
Positive |
Negative |
Positive/Negative |
Positive |
Mantle cell lymphoma |
Positive |
Positive |
Strongly positive |
Negative |
Strongly positive |
Negative |
Follicular lymphoma |
Strongly positive |
Negative |
Positive |
Negative |
Strongly positive |
Negative |
- Adult T-cell leukemia must also be differentiated from other causes of fever, hepatosplenomegaly, and lymph node swelling such as:
- Splenic marginal zone lymphoma
- Nodal marginal zone lymphoma
- Lymphoplasmacytic lymphoma
- Sézary syndrome
References
- ↑ Adult T-cell leukemia/lymphoma. Wikipedia (2015) https://en.wikipedia.org/wiki/Adult_T-cell_leukemia/lymphoma Accessed on November, 3 2015
- ↑ Chuang SS, Ichinohasama R, Chu JS, Ohshima K (May 2010). "Differential diagnosis of angioimmunoblastic T-cell lymphoma with seropositivity for anti-HTLV antibody from adult T-cell leukemia/lymphoma". Int. J. Hematol. 91 (4): 687–91. doi:10.1007/s12185-010-0540-x. PMID 20198459.
- ↑ Hoffbrand V, Moss P. Essential Haematology. John Wiley & Sons; 2011
- ↑ Rodríguez-Zúñiga M, Cortez-Franco F, Qujiano-Gomero E (June 2018). "Adult T-Cell Leukemia/Lymphoma. Review of the Literature". Actas Dermosifiliogr. 109 (5): 399–407. doi:10.1016/j.ad.2017.08.014. PMID 29685460. Vancouver style error: initials (help)